ADR 12.5% 1.4¢ adherium limited

I must admit, it's baffling how the company has allowed itself...

  1. 5,944 Posts.
    lightbulb Created with Sketch. 103
    I must admit, it's baffling how the company has allowed itself to get to a $5m market cap. Surely there is a deal out there ? Before they run out of cash.

    https://bestmarketherald.com/smart-inhalers-market-growth-to-remain-steady-during-the-forecast-
    period/

    Smart Inhalers Market: Competitive Landscape
    Some important players in the smart inhalers market include Teva Pharmaceuticals Industries Ltd., Vectura Group plc, AstraZeneca plc, Propeller Health, Adherium Limited, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Cohero Health LLC, OPKO Health Inc., and Novartis AG.
    Of these, Adherium is a key player in the market with majority of product approvals to its credit. Because smart inhalers is a lucrative market, collaborations and acquisitions between pharmaceutical companies, smart inhaler manufacturers, and medical device companies is on the rise for larger market share. Key players in the smart inhalers market are also focused on product approval and clinical trials to stay competitive in this market.
 
watchlist Created with Sketch. Add ADR (ASX) to my watchlist
(20min delay)
Last
1.4¢
Change
-0.002(12.5%)
Mkt cap ! $10.62M
Open High Low Value Volume
1.5¢ 1.5¢ 1.4¢ $2.688K 186.9K

Buyers (Bids)

No. Vol. Price($)
2 269000 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 28527 1
View Market Depth
Last trade - 10.10am 09/08/2024 (20 minute delay) ?
ADR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.